AU2004284844B2 - Improved blood pump comprising polymeric components - Google Patents
Improved blood pump comprising polymeric components Download PDFInfo
- Publication number
- AU2004284844B2 AU2004284844B2 AU2004284844A AU2004284844A AU2004284844B2 AU 2004284844 B2 AU2004284844 B2 AU 2004284844B2 AU 2004284844 A AU2004284844 A AU 2004284844A AU 2004284844 A AU2004284844 A AU 2004284844A AU 2004284844 B2 AU2004284844 B2 AU 2004284844B2
- Authority
- AU
- Australia
- Prior art keywords
- blood pump
- impeller
- rotary blood
- polymer
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008280 blood Substances 0.000 title claims description 34
- 210000004369 blood Anatomy 0.000 title claims description 34
- 239000000463 material Substances 0.000 claims description 36
- 229920000642 polymer Polymers 0.000 claims description 31
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 17
- 229920002530 polyetherether ketone Polymers 0.000 claims description 17
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 claims description 15
- 239000002131 composite material Substances 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 8
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 8
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 8
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- 239000002033 PVDF binder Substances 0.000 claims description 5
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 5
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 4
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 238000005468 ion implantation Methods 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 description 19
- 239000011347 resin Substances 0.000 description 15
- 229920005989 resin Polymers 0.000 description 15
- 229920002635 polyurethane Polymers 0.000 description 11
- 239000004814 polyurethane Substances 0.000 description 11
- 239000004698 Polyethylene Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000004800 polyvinyl chloride Substances 0.000 description 9
- 229920000915 polyvinyl chloride Polymers 0.000 description 9
- 239000004743 Polypropylene Substances 0.000 description 8
- 239000004793 Polystyrene Substances 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 229920000139 polyethylene terephthalate Polymers 0.000 description 8
- 239000005020 polyethylene terephthalate Substances 0.000 description 8
- 238000010276 construction Methods 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- -1 Polyethylene Polymers 0.000 description 6
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000010526 radical polymerization reaction Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 3
- 229910010293 ceramic material Inorganic materials 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920002492 poly(sulfone) Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000005587 carbonate group Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006353 environmental stress Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- 229920006260 polyaryletherketone Polymers 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 229920006012 semi-aromatic polyamide Polymers 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 229920002430 Fibre-reinforced plastic Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229920000571 Nylon 11 Polymers 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 229920010524 Syndiotactic polystyrene Polymers 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011354 acetal resin Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910003481 amorphous carbon Inorganic materials 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011151 fibre-reinforced plastic Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910001867 inorganic solvent Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000005609 naphthenate group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012994 photoredox catalyst Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001692 polycarbonate urethane Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006126 semicrystalline polymer Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Description
WO 2005/042064 PCT/AU2004/001490 1 IMPROVED BLOOD PUMP COMPRISING POLYMERIC COMPONENTS Field of Invention The present invention relates to an improved implantable blood pump 5 comprising polymeric components. Background of Invention Previously, congestive heart failure may have been treated with the use of blood pump to assist the pumping of blood around the circulatory system of a patient. 10 US Patent 6,609,883 - Woodard et al describes a blood pump fabricated mainly from Titanium-6 Aluminium-4 Vanadium (Ti-6Al-4V) coated with amorphous carbon and/or diamond-like coatings. In particular, the pump housing of this blood pump is metallic and includes a magnetic drive motor acting on a hydrodynamic impeller within the pump housing. One of the disadvantages with this invention is that as the pump 15 housing is entirely constructed of metal, electrical eddy currents form between the motor stators and permanent magnets positioned within the impeller. These electrical eddy currents significantly reduce the electrical efficiency of the blood pump and may lead to increased power consumption. Another US Patent 6,158,984 - Cao et al describes a modified blood pump in 20 which structural members are inserted within the pump housing between the motor stators and the impeller. These structural members are constructed of a biocompatible, corrosion resistant, electrically non-conductive (insulative) ceramic material. One of the disadvantages with the structural members being comprised of ceramic material is that ceramic material is relatively expensive and difficult to construct. The ceramic 25 material may include a diamond like coating which may be particularly costly to produce and prone to flaking. It has been previous known to this field, that rotary blood pumps may be entirely constructed from polymeric material except for the motor components. However, pumps that are entirely constructed of polymeric materials may lack the desired: wear 30 resistance or strength, fluid impermeability and bio-resistance necessary for this type of 2 application. These types of pumps commonly warp or distort due to fluid absorption limiting their usefulness. It is an object of the present invention to address or ameliorate one or more of the abovementioned disadvantages. 5 Brief Description of the Invention In accordance with a first aspect the present invention consists in a rotary blood pump including: a motor adapted to magnetically rotate an impeller within a housing; characterised in that the impeller or the housing are formed of a composite material and 10 said composite material includes a first material that is a relatively, insulative, biocompatible and impermeable polymer, and wherein the pump includes an insulative member formed from said first material and is disposed between portions of the motor to reduce eddy currents losses. Preferably the composite material includes a second material that reinforces the 15 polymer. Preferably said first material has been surface modified by treatment of plasma immersion ion implantation. Preferably said impeller includes magnets that are encapsulated by an impermeable fluid barrier. 20 Preferably said first material is: PEEK, FRP, PC, PS, PEPU, PCU, SiU, PVC, PVDF, PE, PMMA, ABS, PET, PA, AR, PDSM, SP, AEK, T, MPP or a combination thereof. Preferably said impeller is hydrodynamically suspended. In accordance with a second aspect the present invention consists in a rotary blood pump including: a motor adapted to magnetically rotate a hydrodynamically suspended 25 impeller within a housing; characterised in that the impeller and/or the housing are formed of a composite material, said pump including at least one insulative member disposed between portions of said motor to reduce eddy current losses and said insulative member is substantially formed from a biocompatible and impermeable polymer. 30 Preferably said composite material includes a metal metallic alloy. Preferably said metallic alloy is a titanium alloy.
rf Ul/AU2UU4/UU149U Received 4 March 2005 3 Brief Description of Drawings Embodiments of the invention will now be described with reference to the drawings in which: Fig. 1 shows a cross-sectional view of a first preferred embodiment of the 5 present invention; Fig. 2 shows an enlarged cross sectional view of a portion of the preferred embodiment shown in Fig. 1; and Fig. 3 shows an enlarged rotated top view of a portion of the preferred embodiment shown in Fig. 1. 10 Detailed Description of Embodiments A first embodiment of the present invention is shown in Fig. 1. In this embodiment, a blood pump 13 made of a composite material, wherein the composite material includes at least a portion of polymer material reinforced with a second 15 material which may preferably be titanium alloy or other wear resistance and biocompatible material. This blood pump 13 may include: an inlet 1 and an outlet 8; an impeller 2 which rotates and propels blood from the inlet 1 using centrifugal propulsion through the pump housing 6 to the outlet 8; a motor generates the torque force for rotating the impeller 2, the motor is formed by the interaction of the stators 5 axially 20 mounted within the pump housing 6 interacting with magnetic regions in the impeller 2. Preferably, the impeller 2, in use, is hydrodynamically suspended on a fluid bearing formed by a restriction gap 9 between the blades 3 of impeller 2 and the inner wall of the pump housing 6. The impeller 2 preferably includes four blades 3 joined together by struts 4 in a generally square configuration. 25 Preferably positioned between the stators 5 and the magnetic regions of the impeller 2 is an insulative member 7. This insulative member 7 is electrically non conductive and may be constructed of polymers. The insulative member 7 functions so as to prevent or minimise the build up of electrical eddy currents between the stators 5 and magnetic regions of the impeller 2. The eddy currents interfere with the transfer of 30 EMF onto the impeller 2 and may lead to a reduction of electrical efficiency. Once the eddy currents are reduced or minimised, the efficiency of the motor is greatly improved.
r% 1/1XUZUU4/UU149U Received 4 March 2005 4 This insulative member 7 may be encapsulated within the housing 6, as shown in Fig 1, or embedded within the inner wall of the housing 6. Additionally, Fig. 2 shows a cross sectional view of a blade 3. Generally, this blade 3 is made or constructed of a polymeric material. This polymeric material is 5 shown as a layer which forms an insulative member 7a around the outer surface of the blade 3. Encapsulated within the blade 3 is a permanent magnet 11 surrounded by the insulative member 7a. As permanent magnets 11 may be generally comprised of bio toxic compounds, it may be necessary to prevent the bio-toxic material from contacting the blood in the pump 13, when in use. 10 Most polymeric materials are at least partially susceptible to fluid permeation and as such bio-toxic compounds may degrade and release toxic chemicals or compounds in a patient's circulatory system. Therefore, it may be also preferable to coat the insulative member 7a in an impermeable barrier 12 to block, stop or greatly impede the eluting or release of bio-toxic compounds or chemicals into the patient's 15 blood stream. The barrier 12 may also preferably encapsulate, coat and seal the permanent magnet 11. Preferably, these barriers 12 may be constructed from gold, zinc, ParaleneTM or similar impermeable coating material. Additionally the insulative member 7 may be surface modified so as to confer to the surface of the insulative member properties such 20 as impermeability to fluids. These barriers 12 may be usable in any embodiment wherein the insulative member 7 is required to be sealed from the environment. The insulative members 7 and 7a may be surface modified by plasma immersion ion implantation which may chemically alter the surface of the insulative members 7 and 7a to increase their hardness, durability and impermeability to fluids. 25 In Fig. 3, an enlarged top view of a preferred insulative member 7 is shown. This figure depicts a relatively flat disc shaped insulative member 7 mounted with three coils of wire forming the motor stators 5. This relatively flat insulative member may be adapted to fit in the lower inner surface of the housing 6 shown in Fig. 1. Alternately, the insulative member 7 may be modified to form a general cone shape suitable for use 30 within the upper inner surface of the housing 6. The following polymeric substances are examples of materials from which the embodiments may be constructed.
iiU 1/A U4AUf/UU199U Received 4 March 2005 5 Polyetheretherketone ('PEEK') An example of a polymeric material that may be used in the constructions of an embodiment is PEEK. It has a relatively high thermal stability compared with other thermoplastics. It typically retains high strength at elevated temperatures, and has 5 excellent chemical resistance (being essentially inert to organics, and has a high degree of acid and alkali resistance). It has excellent hydrolytic stability and gamma radiation resistance. Therefore PEEK may be readily sterilised by different routes. It also shows good resistance to environmental stress cracking. It generally has excellent wear and abrasion resistance and a low coefficient of friction. PEEK may incorporate glass and/or 10 carbon fibre reinforcements which may enhance the mechanical and/or thermal properties of the PEEK material. PEEK may be easily processed on conventional extrusion and injection moulding equipment. Post-annealing and other processes obvious to a person skilled in the art may be preferable. A polyaromatic, semicrystalline polymer may also be used in 15 construction of an embodiment. Other examples of this polymer include: Polyaryletherketone ('PAEK') manufactured by Vicktrex and PEEK-OPTIMA LTTM which is a polymer grade with properties optimised for long-term implants. PEEK-OPTIMA LT T M is significantly stronger than traditional plastics currently available. Generally, PEEK may be able to 20 withstand more aggressive environments and maintain impact properties over a broader range of temperatures than other polymers. It has been shown that carbon fibre reinforced PEEK found to exhibit excellent resistance to a saline environment at 37'C designed to simulate human body conditions. PEEK includes the significant advantage of generally supplying dimensional 25 stability, when in use. Fibre reinforced polymer ('FRP') Another example of a polymeric material that may be included within an embodiment of the present invention is FRP. FRPs are constructed of composites of PEEK and other polymers. PEEK may be reinforced with 30% short carbon fibres and 30 which when subjected to saline soaking, was found to exhibit no degradation in mechanical properties. In contrast, a 30% short carbon fibre reinforced polysulphone PCT/AU2004/001490 Received 4 March 2005 6 composite has been found to show degraded mechanical properties due to the same saline soaking. The fibre /matrix bond strength may significantly influence the mechanical behaviour of FRP composites. Interfacial bond strength durability is therefore 5 particularly important in the development of FRP composites for implant applications, where diffused moisture may potentially weaken the material over time. Testing in physiologic saline at 37*C showed that interfacial bond strengths in carbon fibre/polysulfone and carbon fibre/polyetheretherketone composites significantly decrease. 10 It should be noted that the fibre/matrix bond strength is known to strongly influence fracture behaviour of FRP composites. Polycarbonate ('PC') Another example of polymer material that may be used in the construction of a preferred embodiment are PC resins. PC resins are widely used where transparency and 15 general toughness are sought. PC resins are intrinsically amorphous due to the large bulky bis-phenol component. This means that the polymer has a significantly high free volume and coupled with the polar nature of the carbonate group, the polymer can be affected by organic liquids and by water. PC resins are not as resistant to extremes in pH as PEEK 20 however they are at least partially resistant. PC resins generally have very low levels of residual monomers and so PC resins may be suitable for blood pump construction. PC resins generally have desirable mechanical and thermal properties, hydrophobicity and good oxidative stability. PC resins are desirably used where high impact strength is an advantage. PC resins also 25 generally confer good dimensional stability, reasonable rigidity and significant toughness, at temperatures less than 140'C. PC resins may be processed by all thermoplastic processing methods. The most frequently used process is injection moulding. Please note that it may be necessary to keep all materials scrupulously dry due to small but not negligible moisture pick-up of 30 this resin. The melt viscosity of the resin is very high, and so processing equipment should be rugged. Processing temps of PC resins are relatively high generally being between approximately 230'C and 300'C.
fU 1/AUZUU4/UU14'JU Received 4 March 2005 7 Polysulphone ('PS') Another example of a polymeric material that may be used to construct parts of an embodiment from is PS. PS has relatively good high temperature resistance, and rigidity. PC is generally tough but not notch-sensitive and is capable of use up to 5 140*C. It has excellent hydrolytic stability and is able to retain mechanical properties in hot and wet environments. PS is generally chemically inert. PS is similar to PC resins but may be able to withstand more rigorous conditions of use. Additionally, PS is generally more heat resistant, and possesses a greater resistance to creep and better hydrolytic stability. PC has a high thermal stability 10 generally due to bulky chemical side groups and rigid chemical main backbone chains. It is also generally resistant to most chemicals. Injection moulding used for lower melt index grades, whilst extrusion and blow moulding is used to form components generally made of higher molecular weight PS. Polyurethanes (PU) 15 Another example of a polymeric material that may be include within an embodiment of the present invention is PU. PU is one of the most biocompatible and haemocompatible polymeric materials. PU has the following properties: elastomeric characteristics; fatigue resistance; compliance and acceptance or tolerance in the body during healing; propensity for bulk and surface modification via 20 hydrophilic/hydrophobic balance or by attachments of biologically active species such as anticoagulants or bio-recognisable groups. Bio-modification of PU may be possible through the use of a several antioxidants used in isolation or in combination. These antioxidants may include vitamin E, which may create materials which can endure in a patient's body for several years. 25 PU constitutes one of the few classes of polymers that include the properties of being generally highly elastomeric and biocompatible. 1. Polyether Polyurethanes ('PEPU') Another polymeric material that may be used in the construction of an embodiment is PEPU. PEPU generally has: relatively good flexural performance and 30 acceptable blood compatibility. 2. Polycarbonate Urethane ('PCU') PCT/AU2004/001490 Received 4 March 2005 8 PCU may also provide another alternative polymeric material for the purpose of constructing an embodiment. PCU has significantly lower rates of water transmission or impermeability. This is due to inherently lower chain mobility of the carbonate structure in the soft segment phase. Additional impermeability to water vapour can be 5 achieved by selecting a polyurethane polymer with high hard segment content, and aromatic rather than aliphatic di-isocyanate co-monomer, and a more hydrophobic surface. PCU generally has oxidative stability of the carbonate linkage, which reduces the rate of biodegradation tremendously as compared to the polyether polyurethanes. 10 Siloxane-Urethanes ('SiU') SiU is another example of an alternative preferred polymeric material. SiU generally has a combination of properties including: fatigue strength, toughness, flexibility and low interaction with plasma proteins. However these polymers may be relatively soft. 15 Polyvinylchloride ('PVC') PVC is another example of an alternative preferred polymeric material. PVC is a relatively amorphous and rigid polymer which in the absence of plasticiser has a glass transition around Tg 75'C -105 C. It is a cheap tough polymer which is extensively used with many types of filler and other additives. Although it has a high melt viscosity 20 and therefore in theory is difficult to process, specialised methods have been established for several decades to compound this polymer efficiently. Extraction-resistant grades of PVC are required for long-term blood compatibility. Plasticised PVC has been well established for blood bags and similar devices, and resin manufacturers can keep toxic residual monomer levels acceptably 25 low (<lppm). However there is enormous social pressure to outlaw PVC despite scientific data which generally indicates that PVC is benign. 3. Poly vinylidene fluoride ('PVDF') PVDF is a polymer that possesses relatively good amounts of toughness and biocompatibility to be suitable for use in constructing an embodiment. 30 Polyethylene ('PE') PE is available in several major grades, including Low Density PE ('LDPE'), High Density PE ('HDPE') and Ultra High Molecular Weight Grade PE ('UHMWPE').
PCT/AU2004/001490 Received 4 March 2005 9 However the UHMWPE may be likely to be the most suitable as it generally possesses relative toughness, low moisture absorption, and good overall chemical resistance. Sintered and compression moulded UHMWPE has been well established for hip joints replacement. However further improvements appear necessary, as abrasive 5 resistance and wear are not suitable for lengthy (>5-10 year) use. A major limitation of PE is thermal performance (melting point approximately 130C) and dimensional stability. Polypropylene ('PP') Another suitable polymeric material is PP. PP is a versatile polymer that may 10 possess a combination of features including: relative inertness, relatively good strength and good thermal performance. Depending on the grade, Tg ranges from O'C to -20"C and the MPt is approximately 170C. The most common grades are homo- and ethylene copolymers, the latter with improved toughness. In addition, there have been many advances in reactor technology leading to 15 grades which are either much softer than normal or much stiffer. For example, the Bassell AdstiffTM polymers made using CatalloyTM technology may be suitable and/or include desirable features for use in the manufacture of a blood pump. Generally, PP polymers lack the high melting point of PEEK, but this property is not generally desired. 20 Polymethylmethacrylate (PMMA) PMMA is an amorphous material with good resistance to dilute alkalis and other inorganic solutions, and has been shown to be one of the most biocompatible polymers. Therefore, PMMA may include some of the desirable features and may be used in the construction of an embodiment of the present invention. Generally, PMMA easily 25 machined with conventional tools, moulded, surface coated and plasma etched. PMMA's may be susceptible to environmental stress cracking although this is usually associated with the use of organic solvents, not present in a patient's body and a blood pump working environment. Acrylonitrile-Butadiene-Styrene Terpolymers (ABS) 30 ABS generally have relatively good surface properties including: hardness, good dimensional stability and reasonable heat resistance (Tg approximately 120"C). The PCT/AU2004/001490 Received 4 March 2005 10 combination of the three monomers imparts stiffness (styrene), toughness (butadiene) and chemical resistance (acrylonitrile). Other attributes of ABS may include: rigidity, high tensile strength and excellent toughness as well as excellent dimensional accuracy in moulding. ABS is generally 5 unaffected by water, inorganic solvents, alkalies; acids; and alcohols. However certain hydrocarbon solvents, not usually present within the body of a patient or in the working environment of the blood pump, may cause softening and swelling on prolonged contact. Polyesters ('PET') 10 PET have become one of the largest growing thennoplastics over the past decade: volumes and prices are now approaching PE and PP. PET has a Tg around 75"C and melting point of 275'C. It can vary from about 25% to 70% in crystallinity depending on the processing history of the polymer. Physical properties and chemical resistance are very dependant on crystallinity. PET may also have limited dimensional 15 stability, as crystallisation can slowly increase after moulding. PET are generally tough, transparent, stiff and opaque. Another class of PET with a Tg above 100'C is currently available, this polymer is called Polyethylene Naphthenate ('PEN'). PET and PEN may both be suitable for use in the construction of a blood pump. 20 Polyamides and/or Nylons ('PA') PAs and Nylons are characterised by having excellent wear/frictional properties, high tensile impact and flexural strength and stiffness, good toughness and high melting points. Some PAs may include relatively large hydrocarbon spacers between the amide 25 groups. Examples of this type of PA include Nylon 11 and 12 which are generally more hydrophobic (water uptake <1%) than regular varieties of PAs. However the larger spacing leads to a loss in stiffness compared to the other polymers and thermal performance may also be compromised. Fully aromatic polyamides including KevlarTM (para position) and NomexTM 30 (meta position) are commercially available and have high stiffness and melting points. Semi-aromatic polyamides are made in Germany (eg TrogamidTM T) and France. These semi-aromatic polyamides generally have good transparency and chemical resistance.
-11/UU+/UU149U Received 4 March 2005 11 Acetal Resins and/or Polyoxymethylene ('AR') AR may be used to construct any one of the preferred embodiments. This class of polymer is strong, hard, and abrasion resistant. It has been evaluated for joint replacement components and other long-term implants. 5 The acetal homo-polymer is prone to salt induced cracking, but copolymers with small amounts of a propylene oxide are possible. AR which contains formaldehyde may be of concern due to possible toxicity of formaldehyde. Polydimethylsiloxane ('PDSM') PDSM may be used to construct any one of the preferred embodiments. This 10 polymer is generally elastomeric. It may also be considered for use as either a biocompatible coating or a copolymer. Copolymers based on PDMS and PU have been developed and PDMS/PC is commercially offered by General Electric as LexanTM 3200. The latter is a fairly stiff transparent material with excellent UV performance. 15 Syndiotactic Polystyrene ('SP') SP may be used to construct any one of the preferred embodiments. SP is typically highly crystalline, little change in modulus occurs at the Tg of 100'C, and retention of properties is fairly high to the melting point of over 250*C. Many grades may be fibre reinforced, to further reduce the change in modulus at the Tg. Being a 20 hydrocarbon with no hetero atoms, the polymer may be hydrophobic and inert. Aliphatic ether ketones ('AEK') AEK may be used to construct any one of the preferred embodiments. Processing and mechanical performance are similar, but this polymer shows improved high temperature aging behaviour and little notch sensitivity. Unfortunately the 25 material lacked distinctiveness and is no longer produced. TOPASTM ('T') T may be used to construct any one of the preferred embodiments. This class of co-polymer is made by Ticona in Gernany. It generally comprises ethylene and norbornadene, with the Tg being controlled by monomer ratio. It is a hydrocarbon 30 alternative to polycarbonate, and is generally suitable for medical fittings and devices.
r% iL/iU4UU4/UU149U Received 4 March 2005 12 Its Tg is over approximately 130"C and it is generally transparent with the co-monomer inhibiting crystallisation of the ethylene segments. Metallocene PP ('MPP') MPP may be used to construct any one of the preferred embodiments MPP is 5 manufactured by Exxon to compete with existing PP. It has a much narrower molecular weight distribution (polydispersity around 2) because it is oligomer-free. Various additional modifications are possible within the scope of the foregoing specification and accompanying drawings without departing from the scope of the invention. A mAnd.A "h.-+
Claims (9)
1. A rotary blood pump including: a motor adapted to magnetically rotate an impeller within a housing; characterised in that the impeller or the housing are formed of a composite material and said composite material includes a first material that is a relatively, insulative, biocompatible and impermeable polymer and wherein the pump includes an insulative member formed from said first material and is disposed between portions of the motor to reduce eddy currents losses.
2. The rotary blood pump as claimed in claim 1, wherein the composite material includes a second material that reinforces the polymer.
3. A rotary blood pump as claimed in claim 1, wherein said first material has been surface modified by treatment of plasma immersion ion implantation.
4. A rotary blood pump as claimed in claim 1, said impeller includes magnets that are encapsulated by an impermeable fluid barrier.
5. A rotary blood pump as claimed in claim 1, wherein said first material is: PEEK, FRP, PC, PS, PEPU, PCU, SiU, PVC, PVDF, PE, PMMA, ABS, PET, PA, AR, PDSM, SP, AEK, T, MPP or a combination thereof.
6. The rotary blood pump as claimed in claim 1, wherein said impeller is hydrodynamically suspended.
7. A rotary blood pump including: a motor adapted to magnetically rotate a hydrodynamically suspended impeller within a housing; characterised in that the impeller and/or the housing are formed of a composite material, said pump including at least one insulative member disposed between portions of said motor to reduce eddy current losses and said insulative member is substantially formed from a biocompatible and impermeable polymer.
8. A rotary blood pump as claimed in claim 7 wherein said composite material includes a metal metallic alloy.
9. A rotary blood pump as claimed in claim 8 wherein said metallic alloy is a titanium alloy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004284844A AU2004284844B2 (en) | 2003-10-31 | 2004-10-28 | Improved blood pump comprising polymeric components |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003906051 | 2003-10-31 | ||
| AU2003906051A AU2003906051A0 (en) | 2003-10-31 | Improved Blood Pump Comprising Polymeric Components | |
| PCT/AU2004/001490 WO2005042064A1 (en) | 2003-10-31 | 2004-10-28 | Improved blood pump comprising polymeric components |
| AU2004284844A AU2004284844B2 (en) | 2003-10-31 | 2004-10-28 | Improved blood pump comprising polymeric components |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2004284844A1 AU2004284844A1 (en) | 2005-05-12 |
| AU2004284844B2 true AU2004284844B2 (en) | 2009-12-03 |
Family
ID=36480990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004284844A Expired - Fee Related AU2004284844B2 (en) | 2003-10-31 | 2004-10-28 | Improved blood pump comprising polymeric components |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2004284844B2 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5078741A (en) * | 1986-10-12 | 1992-01-07 | Life Extenders Corporation | Magnetically suspended and rotated rotor |
| US5503615A (en) * | 1994-08-26 | 1996-04-02 | Goldstein; Bernard | Implantable cardiac ventricular assist device and controller thereof |
-
2004
- 2004-10-28 AU AU2004284844A patent/AU2004284844B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5078741A (en) * | 1986-10-12 | 1992-01-07 | Life Extenders Corporation | Magnetically suspended and rotated rotor |
| US5503615A (en) * | 1994-08-26 | 1996-04-02 | Goldstein; Bernard | Implantable cardiac ventricular assist device and controller thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004284844A1 (en) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070270633A1 (en) | Blood Pump Comprising Polymeric Components | |
| US10556050B2 (en) | Low cost ventricular device and system thereof | |
| AU2017272906B2 (en) | Ventricle assist device | |
| EP3280358B1 (en) | Prosthetic heart valves having fiber reinforced leaflets | |
| McKeen | 3—Plastics used in medical devices | |
| KR102845743B1 (en) | Self-lubricating medical supplies | |
| KR102561667B1 (en) | Antibacterial, non-clotting polymer composition | |
| EP0986414B1 (en) | Cross-linked nylon block copolymers | |
| JP2019506198A5 (en) | ||
| EP2723409A2 (en) | Polymeric materials | |
| CN113164657A (en) | Self-lubricating medical article | |
| AU2004284844B2 (en) | Improved blood pump comprising polymeric components | |
| EP0218638A4 (en) | Pivot pin bearing for biomedical systems. | |
| CA2411739C (en) | Turbo blood pump | |
| Frommelt | Polymers for medical applications | |
| WO2007063843A1 (en) | Blood pump | |
| AU2005324056B2 (en) | Stopcock closure plug | |
| CN116096767A (en) | Method for forming graft layer, method for producing composite, and treatment liquid for forming graft layer | |
| Boretos et al. | Chapter 4 Biomedical elastomers | |
| Shansong et al. | Improvement of blood compatibility of silicone rubber by the addition of hydroxyapatite. | |
| Powojska et al. | Thermal and physicochemical properties of silicone-based composites reinforced with silanized magnetic powder | |
| George | An Introduction to Polymeric Materials for Medical Devices | |
| Benard et al. | A study of biocompatible materials used for cardiovascular prostheses | |
| Trostyanskaya et al. | Creation of boundary layers in phenolic plastics reinforced with various types of fibre | |
| JPH11114050A (en) | Blood adaptable material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK25 | Application lapsed reg. 22.2i(2) - failure to pay acceptance fee |